PRESENCE OF THE TUMOR-ASSOCIATED ANTIGENS CA-50 AND CA-19-9 IN ENDOMETRIAL CANCER

被引：0
|
作者：
GOHRING, UJ
WEBER, F
SCHARL, A
BOLTE, A
机构：
[1] Universitäts-Frauenklinik Köln, Köln, D-50937
来源：
ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 1993年 / 254卷 / 1-4期
关键词：
D O I：
10.1007/BF02266273
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：993 / 995
页数：3
相关论文
共 50 条
  • [41] THE EFFECT OF NON-INSULIN-DEPENDENT DIABETES ON SERUM CONCENTRATIONS OF TUMOR-ASSOCIATED CARBOHYDRATE ANTIGENS OF CA19-9, CA-50, AND SIALYL SSEA-1 IN ASSOCIATION WITH THE LEWIS BLOOD PHENOTYPE
    SHIMOJO, N
    NAKA, K
    NAKAJIMA, C
    ISHIZAKI, T
    OKUDA, K
    MURAI, J
    YAMAMOTO, M
    CLINICA CHIMICA ACTA, 1990, 190 (03) : 283 - 289
  • [42] PROSPECTIVE CLINICAL-EVALUATION OF THE DIAGNOSTIC-ACCURACY OF MONOCLONAL (CA-19-9, CA-50, CA-12-5) AND POLYCLONAL (CEA, TPA) ANTIGENS IN RESPECT TO PANCREATIC-CARCINOMA
    BENINI, L
    CAVALLINI, G
    ZORDAN, D
    RIGO, L
    RIZZOTTI, P
    PEROBELLI, L
    BROCCO, G
    PEDERZOLI, P
    RIELA, A
    SCURO, LA
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1987, 19 (01): : 54 - 55
  • [43] PREDICTIVE VALUE OF THE TUMOR-MARKERS NEURON-SPECIFIC ENOLASE, CA-19-9, CA-125, CA-15-3 AND CA-50 IN BENIGN AND MALIGNANT LUNG-DISEASES
    WOROFKA, B
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (11): : 780 - 780
  • [44] SERUM LEVELS OF CA-19-9 AND CA-50 IN RELATION TO LEWIS BLOOD-CELL STATUS IN PATIENTS WITH MALIGNANT AND BENIGN PANCREATIC DISEASE
    VONROSEN, A
    LINDER, S
    HARMENBERG, U
    PEGERT, S
    PANCREAS, 1993, 8 (02) : 160 - 165
  • [45] The role of CA-19-9, CA 242 and CEA tumor markers in digestive tract cancer diagnostics
    Hasmik, Vahradyan
    Hasmik, Harutyunyan
    Qnarik, Aleqsanyan
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S209 - S209
  • [46] CA-19-9、CA-50、CEA联检在直肠癌放疗前后疗效观察中的意义
    李汉银
    放射免疫学杂志, 1996, (06) : 344 - 345
  • [47] Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma
    Grankvist, K
    Ljungberg, B
    Rasmuson, T
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (02) : 233 - 236
  • [48] Role of CA-19-9 in Treatment of Pancreatic Cancer: Do We Have Better Marker Than CA-19-9?
    Kim, Y. J.
    Yang, K. Y.
    Seo, J. K.
    Park, J. K.
    Ryu, J. K.
    Kim, Y. -T.
    Yoon, Y. B.
    Lee, S. H.
    Hwang, J. H.
    Jeong, J. B.
    Jang, J. -Y.
    Kim, S. -W.
    PANCREAS, 2009, 38 (08) : 1016 - 1016
  • [49] THE DIAGNOSTIC-VALUE OF TUMOR ASSOCIATED CA-19-9 ANTIGEN LEVEL IN PANCREATIC-CANCER
    SAMOILENKO, VM
    AFRIKYAN, MN
    ITIN, AB
    VOPROSY ONKOLOGII, 1989, 35 (09) : 1050 - 1053
  • [50] CA-125 AND CA-19-9 - 2 CANCER-ASSOCIATED SIALYLSACCHARIDE ANTIGENS ON A MUCUS GLYCOPROTEIN FROM HUMAN-MILK
    HANISCH, FG
    UHLENBRUCK, G
    DIENST, C
    STOTTROP, M
    HIPPAUF, E
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 149 (02): : 323 - 330
12345